Rua Bioscience launches new $2m renounceable rights offer
The listed medicinal cannabis company’s ongoing cash operating losses means ongoing growth can’t be maintained without additional capital to fund required inventory.
NZX-listed medicinal cannabis company Rua Bioscience has launched a renounceable rights offer to shareholders of one new share for every three existing shares to raise up to $2 million.
The issue prices for the rights offer is 2.5 cents a share, representing a 35% discount to the five-day volume
